“Our product introduction and initial post-launch results have exceeded our expectations in terms of quickly transitioning patients from our expanded access program and other compassionate use programs, securing insurance coverage for all eligible patients and delivering an extremely high level of patient satisfaction as determined by our direct surveys.
They have done everything they said they would and more.”
-Catalyst Pharmaceuticals